Tag: non therapeutic biomolecules market share

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Non-Therapeutic Biomolecules Industry Expected To Reach By 2029, Starting From 2025 Levels?

The non-therapeutic biomolecules market has experienced substantial expansion in recent years. Its valuation is projected to increase from $30.76 billion in 2024 to $33.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.3%. The market’s past growth can be attributed to factors such as increased research and development (R&D) investments, expanding applications in research and diagnostics, rising awareness and adoption, strategic collaborations and partnerships, and regulatory support.

The non-therapeutic biomolecules market is projected to experience swift expansion over the coming years. This market is set to reach $51.03 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.8%. The anticipated growth during this period stems from factors such as new market opportunities, progress in data analytics and integration, a heightened emphasis on precision medicine, increased funding in personalized healthcare, and broader application domains. Key developments expected during the forecast period encompass technological innovations, strategic partnerships, a surge in agricultural applications, an enlarged presence in industrial processes, and enhanced customization along with personalization.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

Which Drivers Are Impacting The Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecules market is projected to grow as the number of research and laboratory testing procedures rapidly increases. Laboratory testing refers to a medical process involving the analysis of blood, urine, or other bodily substances to identify and monitor diseases, thereby aiding in the creation of a treatment plan. Research, on the other hand, involves the generation of new knowledge or the innovative application of existing knowledge to establish new concepts, theories, and understandings. Non-therapeutic biomolecules are utilized in laboratory testing to assess the presence or concentration of a biomarker molecule indicative of disease, thereby enhancing the test’s sensitivity and specificity. For example, in July 2024, the National Health Service (NHS), a UK-based hospital and healthcare provider, stated that diagnostic activity in 2023 had surpassed pre-pandemic levels, with a 21% increase in tests performed in May 2024 compared to the previous year. Therefore, the rapidly growing volume of research and laboratory testing is a key driver for the expansion of the non-therapeutic biomolecules market.

What Are The Leading Segments Analyzed In The Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

Which Competitive Trends Are Defining The Non-Therapeutic Biomolecules Market Structure?

Product innovation is a prominent trend gaining traction in the non-therapeutic biomolecules market. Leading companies operating in this sector are concentrating on research and development for product advancements to maintain their market position. For instance, in January 2022, BASF SE, a Germany-based multinational chemical company, partnered with Caregen, a Korean-based firm specializing in biomimetic peptide research and development. This collaboration led to the introduction of the Peptovitae series, manufactured using liposome-encapsulation technology, aiming to expand BASF’s dermo-cosmetics portfolio and offer innovative, differentiated solutions for a wide array of skin concerns. Liposomal encapsulation is a technique that utilizes fats to deliver essential vitamins or medications to specific body sections within tiny bubbles, without affecting other body parts. The Peptovitae series addresses a broader spectrum of skin issues than typically associated with peptides, such as signs of aging, enhancing skin brightness, soothing skin prone to dryness and itching, and moisturizing the skin.

Which Global Market Leaders Are Shaping The Future Of The Non-Therapeutic Biomolecules Sector?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

How Do Regional Market Performances Compare Within The Non-Therapeutic Biomolecules Industry?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Non-Therapeutic Biomolecules Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

Browse Through More Reports Similar to the Global Non-Therapeutic Biomolecules Market 2025, By The Business Research Company

Small Animal Imaging In Vivo Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Biologics Market 2025

https://www.thebusinessresearchcompany.com/report/biologics-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Non-Therapeutic Biomolecules Market Heading Into 2029?

The marketplace for non-therapeutic biomolecules has experienced rapid expansion in the past few years. The market value will increase from $30.76 billion in 2024 to $33.92 billion in 2025, projecting a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historical period is due to factors such as heightened investment in research and development (R&D), expanding applicability in research and diagnostic fields, increasing awareness and adoption, strategic collaborations and agreements, and supportive regulatory frameworks.

The market size of non-therapeutic biomolecules is projected to swiftly expand in the near future, swelling to “$51.03 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. The anticipated expansion during this forecasted timeframe is due to diverse factors such as the evolution of new market opportunities, the progressive advancements in data analytics and integration, an intensified focus on precision medicine, heightened investments in personalized healthcare, and broader application areas. Among the major trends expected to appear during this forecast period are technological progression, mutual strategic partnerships, surging applications in the agriculture sector, a growing influence in industrial procedures, along with customization and personalization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

Which Factors Are Pushing The Non-Therapeutic Biomolecules Market Forward?

The non-therapeutic biomolecules market is anticipated to grow due to the rapidly escalating volume of research and laboratory tests. Laboratory testing involves medical procedures that test samples of blood, urine, or other substances in the body to diagnose diseases, monitor their progress, and formulate a treatment plan. On the other hand, research tasks create new knowledge or apply existing knowledge creatively to develop new concepts, theories, and understanding. In laboratory testing, non-therapeutic biomolecules are employed to detect the presence or level of biomarker molecules indicative of disease, thus increasing the test’s sensitivity and specificity. For example, the National Health Service (NHS), a UK-based hospital, and healthcare provider, reported in July 2024 that diagnostic activity surpassed pre-pandemic levels in 2023, recording a 21% surge in tests conducted in May 2024 compared to the same month the previous year. This burgeoning volume of research and laboratory testing is thus fueling the expansion of the non-therapeutic biomolecules market.

Which Segment Held The Largest Share In The Non-Therapeutic Biomolecules Market In 2025?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

Which Emerging Trends And Strategic Shifts Are Shaping The Non-Therapeutic Biomolecules Market?

A notable trend occurring in the non-therapeutic biomolecules market is product innovation. Dominant entities in this field are dedicating resources towards research and development in an endeavor to maintain their market standing. In January 2022, an example of this was illustrated when BASF SE, a multinational chemical company based in Germany, entered into a strategic partnership with Caregen, a biomimetic peptide research and development firm based in Korea. Together, they launched the Peptovitae series, utilizing liposome encapsulated technology. This series has been added to the company’s dermo-cosmetic portfolio, providing a range of innovative and unique solutions for various skin concerns. Liposomal encapsulation involves using fats to selectively deliver essential vitamins or medications within the body while minimizing impact on unrelated sections of the body. The Peptovitae series surpasses the traditional peptide applications, addressing problems including signs of aging, enhancing skin radiance, soothing dry and itchy skin, and skin hydration.

Which Organizations Are Driving Progress In The Non-Therapeutic Biomolecules Industry?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Non-Therapeutic Biomolecules Industry?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Non-Therapeutic Biomolecules Market Heading Into 2029?

The market for non-therapeutic biomolecules has seen swift growth in the recent past. The market value is projected to increase from $30.76 billion in 2024 to $33.92 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. The historic growth can be credited to climbing investments in research and development (R&D), expanding use in research and diagnostics, burgeoning adoption and awareness, strategic alliances and partnerships, as well as regulatory backing.

Anticipated to expand rapidly in the subsequent years, the non-therapeutic biomolecules market is set to reach a valuation of $51.03 billion by 2029, with an impressive compound annual growth rate (CAGR) of 10.8%. This projected rise in the forecast period is driven by the emergence of new market opportunities, progresses in data analysis and amalgamation, a mounting focus on precision medicine, increased investments into personalized healthcare, and wider application scope. The forecast period is also expected to see certain key trends such as technological advancements, strategic partnerships, a surge in applications in the agriculture sector, a broadening role in industrial procedures, and an emphasis on customization and personalization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

Which Factors Are Pushing The Non-Therapeutic Biomolecules Market Forward?

The non-therapeutic biomolecules market is predicted to expand due to the escalating number of research and laboratory tests. Laboratory tests are medical procedures that involve examining bodily samples like blood or urine to identify and track diseases and devise treatment strategies. On the other hand, research involves producing new knowledge or innovatively applying existing knowledge to generate fresh concepts, theories, and comprehensions. Non-therapeutic biomolecules prove useful in lab tests when gauging the existence or concentration of a biomarker molecule denoting disease, thereby increasing the test’s sensitivity and specificity. To illustrate, the UK’s National Health Service (NHS) reported a rise beyond pre-pandemic levels in diagnostic activity in 2024, with diagnostic tests in May 2024 showing a 21% increase as compared to the previous year. Hence, the surging number of research and laboratory tests is fueling the growth of the non-therapeutic biomolecules market.

Which Segment Held The Largest Share In The Non-Therapeutic Biomolecules Market In 2025?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

How Are Key Trends Driving Expansion In The Non-Therapeutic Biomolecules Industry?

The emergence of product innovations is a notable trend in the non-therapeutic biomolecules market. To maintain their market leadership, predominant companies are investing heavily in research and development for these unique innovations. For example, in January 2022, Caregen, a firm based in Korea dedicated to biomimetic peptide research and development, formed a partnership with BASF SE. This German multinational chemical company subsequently launched the Peptovitae series, which was produced using liposome-encapsulation technology, thus broadening its dermo-cosmetics range to offer diverse and inventive solutions for a variety of skin issues. This encapsulation technique employs fats to transport necessary vitamins or medicines to certain areas of the body in minuscule bubbles while leaving other parts unaffected. The Peptovitae series caters to a more extensive selection of skin problems than what peptides commonly address, such as aging signs, skin dryness, itchiness, and the need for hydration.

Which Organizations Are Driving Progress In The Non-Therapeutic Biomolecules Industry?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Non-Therapeutic Biomolecules Industry?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Non-Therapeutic Biomolecules Market Growth in 2025?

The size of the non-therapeutic biomolecules industry has undergone swift expansion in the past few years. Its growth is expected to accelerate from $30.76 billion in 2024 to $34.23 billion in 2025, marking a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this growth during the historical timeline include upsurged investments in research and development (R&D), growing usage in research and diagnostics, heightened awareness and acceptance, strategic alliances and partnerships, and regulatory aid.

What Is the Forecast for the Non-Therapeutic Biomolecules Market Size Through 2029?

Expectations are high for a swift expansion in the non-therapeutic biomolecules market in the subsequent years. The projected size by 2029 is $52.15 billion, with an 11.1% compound annual growth rate (CAGR). Factors contributing to the anticipated growth in the forecast period include the emergence of new market prospects, advancements in data analytics and integration, increased focus on precision medicine, augmented investments in personalized healthcare, and widening application areas. The upcoming period is also expected to witness noteworthy trends such as technological advancements, strategic collaborations, growing use in agriculture, increased involvement in industrial processes, along with increasing customization and personalization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

What are the Key Market Players in Non-Therapeutic Biomolecules Market and How They’re Evolving?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

What Are the Primary Growth Drivers in the Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecules market’s growth is predicted to be fueled by the fast-paced escalation in research and laboratory testing. Laboratory testing, a medical process that involves examining bodily samples like blood or urine to diagnose and monitor diseases and formulate treatment plans, is coupled with research, a method through which novel knowledge is created or current knowledge is innovatively used to generate new insights, theories, and comprehension. Non-therapeutic biomolecules are utilized in laboratory testing to detect the presence or level of a biomarker molecule indicative of disease, thereby enhancing the test’s sensitivity and specificity. For example, in July 2024, as per the data from the National Health Service (NHS), a hospital and healthcare provider based in the UK, diagnostic activity outpaced the pre-pandemic levels in 2023, showcasing a 21% surge in tests conducted in May 2024 in comparison to the previous year. Hence, the accelerated rise in research and laboratory testing appears to be the driving force behind the growth of the non-therapeutic biomolecules market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

What Are the Leading Segments in the Global Non-Therapeutic Biomolecules Industry?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

What Are the Key Market Trends in the Non-Therapeutic Biomolecules Industry?

The trend of product innovation is emerging prominently in the non-therapeutic biomolecules market, with major players engaging in research as well as development for novel product introductions to maintain dominant market positions. For example, BASF SE, a transnational chemical corporation from Germany, entered into a collaboration with Caregen, a biomimetic peptide R&D entity from Korea, in January 2022. Together, they unveiled the Peptovitae series, a range developed via liposome-encapsulation technology designed to extend its dermo-cosmetic offering. This approach offers innovative, distinct resolutions for a variety of skin issues by directing essential nutrients or medications in small bubbles to certain sections of the body using fat, without impacting other zones. The Peptovitae series caters to a greater scope of skin conditions beyond those typically linked to peptide usage, including age indications, skin brightness enhancement, calming dry, itchy skin and skin hydration.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

What Is the Regional Outlook for the Non-Therapeutic Biomolecules Market?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8769

This Report Delivers Insight On:

1. How big is the non-therapeutic biomolecules market, and how is it changing globally?

2. Who are the major companies in the non-therapeutic biomolecules market, and how are they performing?

3. What are the key opportunities and risks in the non-therapeutic biomolecules market right now?

4. Which products or customer segments are growing the most in the non-therapeutic biomolecules market?

5. What factors are helping or slowing down the growth of the non-therapeutic biomolecules market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Non-Therapeutic Biomolecules Market Growth in 2025?

The size of the non-therapeutic biomolecules industry has undergone swift expansion in the past few years. Its growth is expected to accelerate from $30.76 billion in 2024 to $34.23 billion in 2025, marking a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this growth during the historical timeline include upsurged investments in research and development (R&D), growing usage in research and diagnostics, heightened awareness and acceptance, strategic alliances and partnerships, and regulatory aid.

What Is the Forecast for the Non-Therapeutic Biomolecules Market Size Through 2029?

Expectations are high for a swift expansion in the non-therapeutic biomolecules market in the subsequent years. The projected size by 2029 is $52.15 billion, with an 11.1% compound annual growth rate (CAGR). Factors contributing to the anticipated growth in the forecast period include the emergence of new market prospects, advancements in data analytics and integration, increased focus on precision medicine, augmented investments in personalized healthcare, and widening application areas. The upcoming period is also expected to witness noteworthy trends such as technological advancements, strategic collaborations, growing use in agriculture, increased involvement in industrial processes, along with increasing customization and personalization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

What are the Key Market Players in Non-Therapeutic Biomolecules Market and How They’re Evolving?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

What Are the Primary Growth Drivers in the Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecules market’s growth is predicted to be fueled by the fast-paced escalation in research and laboratory testing. Laboratory testing, a medical process that involves examining bodily samples like blood or urine to diagnose and monitor diseases and formulate treatment plans, is coupled with research, a method through which novel knowledge is created or current knowledge is innovatively used to generate new insights, theories, and comprehension. Non-therapeutic biomolecules are utilized in laboratory testing to detect the presence or level of a biomarker molecule indicative of disease, thereby enhancing the test’s sensitivity and specificity. For example, in July 2024, as per the data from the National Health Service (NHS), a hospital and healthcare provider based in the UK, diagnostic activity outpaced the pre-pandemic levels in 2023, showcasing a 21% surge in tests conducted in May 2024 in comparison to the previous year. Hence, the accelerated rise in research and laboratory testing appears to be the driving force behind the growth of the non-therapeutic biomolecules market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

What Are the Leading Segments in the Global Non-Therapeutic Biomolecules Industry?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

What Are the Key Market Trends in the Non-Therapeutic Biomolecules Industry?

The trend of product innovation is emerging prominently in the non-therapeutic biomolecules market, with major players engaging in research as well as development for novel product introductions to maintain dominant market positions. For example, BASF SE, a transnational chemical corporation from Germany, entered into a collaboration with Caregen, a biomimetic peptide R&D entity from Korea, in January 2022. Together, they unveiled the Peptovitae series, a range developed via liposome-encapsulation technology designed to extend its dermo-cosmetic offering. This approach offers innovative, distinct resolutions for a variety of skin issues by directing essential nutrients or medications in small bubbles to certain sections of the body using fat, without impacting other zones. The Peptovitae series caters to a greater scope of skin conditions beyond those typically linked to peptide usage, including age indications, skin brightness enhancement, calming dry, itchy skin and skin hydration.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

What Is the Regional Outlook for the Non-Therapeutic Biomolecules Market?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8769

This Report Delivers Insight On:

1. How big is the non-therapeutic biomolecules market, and how is it changing globally?

2. Who are the major companies in the non-therapeutic biomolecules market, and how are they performing?

3. What are the key opportunities and risks in the non-therapeutic biomolecules market right now?

4. Which products or customer segments are growing the most in the non-therapeutic biomolecules market?

5. What factors are helping or slowing down the growth of the non-therapeutic biomolecules market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Non-Therapeutic Biomolecules Market Growth in 2025?

The size of the non-therapeutic biomolecules industry has undergone swift expansion in the past few years. Its growth is expected to accelerate from $30.76 billion in 2024 to $34.23 billion in 2025, marking a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this growth during the historical timeline include upsurged investments in research and development (R&D), growing usage in research and diagnostics, heightened awareness and acceptance, strategic alliances and partnerships, and regulatory aid.

What Is the Forecast for the Non-Therapeutic Biomolecules Market Size Through 2029?

Expectations are high for a swift expansion in the non-therapeutic biomolecules market in the subsequent years. The projected size by 2029 is $52.15 billion, with an 11.1% compound annual growth rate (CAGR). Factors contributing to the anticipated growth in the forecast period include the emergence of new market prospects, advancements in data analytics and integration, increased focus on precision medicine, augmented investments in personalized healthcare, and widening application areas. The upcoming period is also expected to witness noteworthy trends such as technological advancements, strategic collaborations, growing use in agriculture, increased involvement in industrial processes, along with increasing customization and personalization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

What are the Key Market Players in Non-Therapeutic Biomolecules Market and How They’re Evolving?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

What Are the Primary Growth Drivers in the Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecules market’s growth is predicted to be fueled by the fast-paced escalation in research and laboratory testing. Laboratory testing, a medical process that involves examining bodily samples like blood or urine to diagnose and monitor diseases and formulate treatment plans, is coupled with research, a method through which novel knowledge is created or current knowledge is innovatively used to generate new insights, theories, and comprehension. Non-therapeutic biomolecules are utilized in laboratory testing to detect the presence or level of a biomarker molecule indicative of disease, thereby enhancing the test’s sensitivity and specificity. For example, in July 2024, as per the data from the National Health Service (NHS), a hospital and healthcare provider based in the UK, diagnostic activity outpaced the pre-pandemic levels in 2023, showcasing a 21% surge in tests conducted in May 2024 in comparison to the previous year. Hence, the accelerated rise in research and laboratory testing appears to be the driving force behind the growth of the non-therapeutic biomolecules market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

What Are the Leading Segments in the Global Non-Therapeutic Biomolecules Industry?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

What Are the Key Market Trends in the Non-Therapeutic Biomolecules Industry?

The trend of product innovation is emerging prominently in the non-therapeutic biomolecules market, with major players engaging in research as well as development for novel product introductions to maintain dominant market positions. For example, BASF SE, a transnational chemical corporation from Germany, entered into a collaboration with Caregen, a biomimetic peptide R&D entity from Korea, in January 2022. Together, they unveiled the Peptovitae series, a range developed via liposome-encapsulation technology designed to extend its dermo-cosmetic offering. This approach offers innovative, distinct resolutions for a variety of skin issues by directing essential nutrients or medications in small bubbles to certain sections of the body using fat, without impacting other zones. The Peptovitae series caters to a greater scope of skin conditions beyond those typically linked to peptide usage, including age indications, skin brightness enhancement, calming dry, itchy skin and skin hydration.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

What Is the Regional Outlook for the Non-Therapeutic Biomolecules Market?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8769

This Report Delivers Insight On:

1. How big is the non-therapeutic biomolecules market, and how is it changing globally?

2. Who are the major companies in the non-therapeutic biomolecules market, and how are they performing?

3. What are the key opportunities and risks in the non-therapeutic biomolecules market right now?

4. Which products or customer segments are growing the most in the non-therapeutic biomolecules market?

5. What factors are helping or slowing down the growth of the non-therapeutic biomolecules market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Non-Therapeutic Biomolecules Market?

The rise in research activities and laboratory tests is predicted to fuel the expansion of the non-therapeutic biomolecules market. Laboratory tests involve analyzing a body sample such as blood or urine to diagnose and monitor diseases and set up a treatment regime, while research aims at generating new knowledge or creatively utilizing existing knowledge to develop novel concepts, theories and understandings. The use of non-therapeutic biomolecules in these tests aids in detecting the presence or concentration of specific biomarkers signaling diseases, thus improving the accuracy and reliability of these tests. For instance, the National Health Service (NHS), a health care provider based in the UK, reported in July 2024 that diagnostic procedures had surpassed the numbers of pre-pandemic times in 2023. Specifically, the number of tests conducted in May 2024 saw an increase of 21% compared to the same time the previous year. Consequently, this surge in research and laboratory tests is contributing significantly to the growth of the non-therapeutic biomolecules market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

#What Long-Term Growth Rate is Expected for theNon-Therapeutic Biomolecules Market Between 2025 and 2034?

The market for non-therapeutic biomolecules has seen significant expansion in the past few years. The market will increase from $30.76 billion in 2024 to $34.23 billion in 2025, with a compound annual growth rate (CAGR) of 11.3%. The factors contributing to the growth during the historic period include an increased investment in research and development (R&D), expanded applications in research and diagnostic fields, an upward trend in awareness and adoption, strategic alliances, and regulatory backing.

The market size for non-therapeutic biomolecules is predicted to experience a quick expansion in the upcoming years, escalating to $52.15 billion in 2029 with a compound annual growth rate (CAGR) of 11.1%. The advancement for the predicted period can be linked to the emergence of new market opportunities, advancements in data analytics and integration, much attention on precision medicine, growing investment in personalized healthcare, broadening application areas. Significant trends during the forecasted period consist of technological progress, strategic partnerships, increasing applications in agriculture, extended role in industrial processes, and more customization and personalization.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8769

What Are the Most Significant Market Trends Transforming theNon-Therapeutic Biomolecules Market?

One of the primary trends observed in the non-therapeutic biomolecules market is product innovation. To maintain a competitive edge, prominent companies in the market are actively engaging in research and development activities. A case in point is the strategic partnership between BASF SE – a multinational chemical company based in Germany – and Caregen – a Korean firm focused on biomimetic peptide research and development. In January 2022, they unveiled the Peptovitae series, which is produced using liposome-encapsulation technology. This newest addition in their dermo-cosmetics line aims to offer novel and unique solutions for a variety of skin issues. The technique utilized, liposomal encapsulation, employs fats to transport vital vitamins or medications encapsulated in minuscule bubbles to targeted bodily regions, leaving other areas unaffected. The Peptovitae series caters to an extensive array of skin needs beyond those typically linked with the application of peptides, such as anti-aging, skin brightening, relief for dry and itchy skin, and skin moisturization.

What Are the Top Market Players Propelling the Growth of theNon-Therapeutic Biomolecules Industry?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Which Primary Segments of the Non-Therapeutic Biomolecules Market Are Driving Growth and Industry Transformations?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smpGlobal Non-Therapeutic Biomolecules Market, Global Non-Therapeutic Biomolecules Market Report, Global Non-Therapeutic Biomolecules Market Trends, Global Non-Therapeutic Biomolecules Market Size

Browse Through More Reports Similar to the Gobal Non-Therapeutic Biomolecules Maret 2025, By The Business Research Company:

Scientific Research And Development Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/scientific-research-and-development-services-global-market-report

Small Animal Imaging (In-Vivo) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Acne Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the non-therapeutic biomolecules market?

The scale of the non-therapeutic biomolecules market has seen a swift increase in recent times. The market, currently worth $30.76 billion in 2024, is anticipated to reach $34.23 billion in 2025, witnessing a compound annual growth rate (CAGR) of 11.3%. The robust growth observed during the historical phase is primarily due to escalated investments in research and development (R&D), expanding utilization in research and diagnostics, growing awareness and acceptance, strategic alliances and partnerships, and regulatory backing.

What will be the non-therapeutic biomolecules market size in the future?

The market size for non-therapeutic biomolecules is anticipated to experience swift expansion in the coming years, reaching $52.15 billion in 2029 with a compound annual growth rate (CAGR) of 11.1%. The predicted growth during this period can be attributed to developing market opportunities, improvements in data analytics and integration, an increased emphasis on precision medicine, amplified investment in personalized healthcare, and broadening application areas. Key trends for the forecast period encompass technological progression, strategic partnerships, increasing uses in agriculture, a growing function in industrial processes, customization, and personalization.

Get your non-therapeutic biomolecules market report here!

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

What main drivers are fueling expansion in the non-therapeutic biomolecules market?

The escalating count of research work along with laboratory tests are potentially contributing to the advancement of the non-therapeutic biomolecules market. This form of laboratory assessment pertains to a medical process where certain samples like blood or urine, among others, are examined to formulate a treatment plan based on the determination and monitoring of a disease. Conversely, research involves conjuring up new ideas and applying current knowledge creatively for new understandings or concepts. Non-therapeutic biomolecules, when applied in the realm of laboratory testing, assist in ascertaining the presence or level of a biomarker molecule, characteristic of a disease, thus fine-tuning the accuracy of the test outcomes. For instance, data from the National Health Service (NHS), UK’s health care provider, revealed that diagnostic activity in July 2024 surpassed the pre-pandemic rates recorded in 2023, showing a 21% rise in tests conducted in May 2024 compared to the previous year. As a result, the non-therapeutic biomolecules market is experiencing growth driven by the progressively increasing research work and laboratory tests.

What key areas define the segmentation of the global non-therapeutic biomolecules market?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

Who are the dominant players expanding their reach in the non-therapeutic biomolecules market?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

How are evolving market trends shaping non-therapeutic biomolecules Strategies?

The emergence of product innovations is a prevailing trend observed in the non-therapeutic biomolecules industry. To maintain their market stance, key companies are focusing on research and development to innovate new products. For instance, in January 2022, BASF SE, a German multinational chemical corporation, collaborated with Caregen, a Korean biomimetic peptide research and development firm. Together, they launched the Peptovitae series, produced with liposome-encapsulation technology, to broaden their dermo-cosmetics offerings and present inventive and distinctive solutions for diverse skin issues. By utilizing liposomal encapsulation, a method that employs fats to carry essential vitamins or drugs in minuscule bubbles to particular areas of the body without disturbing other sections, the Peptovitae series can address a broader assortment of skin ailments beyond traditional peptide applications. This includes signs of ageing, improving skin luminosity, relieving dry and itchy skin, and hydrating the skin.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8769

Which regions are emerging as leaders in the non-therapeutic biomolecules market?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Scientific Research And Development Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/scientific-research-and-development-services-global-market-report

Small Animal Imaging (In-Vivo) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Acne Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Projected Compound Annual Growth Rate (CAGR) of the Non-Therapeutic Biomolecules Market from 2025 to 2034, and What Factors Influence It?

The size of the non-therapeutic biomolecules market has witnessed a swift expansion in recent years. The market is projected to escalate from $30.76 billion in 2024 to $34.23 billion in 2025, with a compound annual growth rate (CAGR) of 11.3%. The surge observed in the earlier period can be credited to heightened investments in research and development (R&D), expanding utilization in research and diagnosis, increasing consciousness and usage, tactical alliances and partnerships, and supportive regulations.

Anticipated to witness a swift expansion in the coming years, the non-therapeutic biomolecules market is projected to reach a valuation of $52.15 billion by 2029, multiplying at a compound annual growth rate (CAGR) of 11.1%. The surge within this period is largely due to the rise of new market opportunities, enhanced data analytics, and integration, a heightened focus on precision medicine, an uptick in investment towards personalized healthcare, and broader application fields. The forecast period will also be characterized by technology progress, strategic alliances, increased applications in agriculture, a wider role in industrial operations, and a greater emphasis on customization and personalization.

Which Major Market Drivers Are Expected to Boost the non-therapeutic biomolecules Market’s Growth Potential?

The non-therapeutic biomolecules market is forecasted to expand due to a swiftly rising number of research activities and laboratory tests. The practice of laboratory testing includes the study of body sample substances like blood or urine in order to analyse and track diseases, and subsequently, formulate treatment plans. Meanwhile, research signifies creating new knowledge or innovatively utilizing current knowledge to establish fresh concepts, theories, and understandings. Non-therapeutic biomolecules are employed in laboratory tests to evaluate the existence or volume of a disease-indicating biomolecular marker, thereby increasing the test’s sensitivity and accuracy. For example, July 2024 data from the National Health Service (NHS), a UK-based hospital and healthcare services provider, showed that diagnostic activities surpassed pre-pandemic numbers in 2023, with a notable increase of 21% in tests conducted in May 2024 compared to the same period the previous year. Therefore, the non-therapeutic biomolecules market is experiencing growth due to the accelerated increase in research activities and laboratory tests.

Request Your Free Non-Therapeutic Biomolecules Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

Who Are the Leading Players Fueling Growth in the Non-Therapeutic Biomolecules Market?

Major companies operating in the non-therapeutic biomolecules market are:

• Amgen Inc._x000D_

• Genentech Inc._x000D_

• Merck KGaA_x000D_

• Lonza Group AG_x000D_

• Bio-Rad Laboratories Inc._x000D_

What Are the Emerging Trends Shaping the Future of the Non-Therapeutic Biomolecules Market?

Innovation in products is emerging as a major trend in the non-therapeutic biomolecules market. Leading companies in the sector are placing a substantial focus on research and development efforts to come up with fresh innovations, thus maintaining their market standing. For example, in January 2022, BASF SE, a multinational chemical corporation based in Germany, teamed up with Caregen, a Korean firm dedicated to biomimetic peptide research and development. Their collaboration led to the creation of the Peptovitae series, which was produced using liposome-encapsulation technology, elevating their portfolio within the dermo-cosmetics realm to cater a broader spectrum of skin-related issues with unique and advanced solutions. The process of liposomal encapsulation incorporates fats to transport vital vitamins or medicines to specific areas of the body in miniscule bubbles, without any impact on the rest of the body. The Peptovitae series extends beyond the customary scope of peptides, addressing various skin issues like signs of aging, skin’s brightness enhancement, providing relief for skin that tends to be dry and itchy, and hydration of the skin.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

How Are the Key Segments of the Non-Therapeutic Biomolecules Market Driving Opportunities and Innovations?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

Which Regions Are Driving Growth in the Non-Therapeutic Biomolecules Market?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the Non-Therapeutic Biomolecules Market?

Non-therapeutic biomolecule refers to the organic compounds created by cells and living things. These compounds come in a wide range of shapes and sizes and carry out a wide variety of tasks in body functioning.

Browse Through More Similar Reports By The Business Research Company:

Scientific Research And Development Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/scientific-research-and-development-services-global-market-report

Small Animal Imaging (In-Vivo) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Acne Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: